•   
  •   
  •   

World Volunteer in Oxford Covid vaccine test dies in Brazil: officials

05:20  22 october  2020
05:20  22 october  2020 Source:   msn.com

Protecting the profits of a few could prevent vaccine access for all

  Protecting the profits of a few could prevent vaccine access for all India and South Africa have put forward a novel proposal to replace our current competition-driven approach with cooperation. At a meeting on Oct. 15, they will be asking the World Trade Organization (WTO) to temporarily relax its rules to allow for more international collaboration in the manufacture of the vaccines and medicines - even without authorization from the companies that created them. Theirs is an ambitious gambit, but one that deserves support. require(["medianetNativeAdOnArticle"], function (medianetNativeAdOnArticle) { medianetNativeAdOnArticle.

Volunteer in Oxford coronavirus vaccine trial dies , reportedly took placebo. RIO DE JANEIRO — A Brazilian who volunteered to receive a leading experimental coronavirus vaccine has died , officials here said AstraZeneca has since resumed the tests in Brazil , India, South Africa, Japan and Britain.

Volunteer in Oxford -AstraZeneca vaccine trial dies in Brazil - but scientists say there are NO Health officials say he was Brazilian but no details about his name, race or where he lived were available. Pictured: Brazilian pediatrician Dr Monica Levi, who received the COVID -19 vaccine

A volunteer participating in clinical trials of the Covid-19 vaccine developed by Oxford University has died in Brazil, officials announced Wednesday, though media reports said he had received a placebo, not the test vaccine.

a man standing in a kitchen preparing food: A clinical trial of a vaccine developed by AstraZeneca and Oxford University will continue despite the death of a volunteer in Brazil, as a review did not reveal safety concerns © Vincenzo PINTO A clinical trial of a vaccine developed by AstraZeneca and Oxford University will continue despite the death of a volunteer in Brazil, as a review did not reveal safety concerns

It is the first death reported in the various coronavirus vaccine trials taking place worldwide.

However, organizers of the study said an independent review had concluded there were no safety concerns and that testing of the vaccine, developed with pharmaceutical firm AstraZeneca, would continue.

Kremlin dismisses vaccine disinformation campaign accusations as 'circus'

  Kremlin dismisses vaccine disinformation campaign accusations as 'circus' Kremlin spokesperson Dmitry Peskov dismissed the reaction of the UK Foreign Secretary Dominic Raab to the Times report saying that Russia is engaging in a disinformation campaign to discredit the Oxford University coronavirus vaccine in an effort to promote its own vaccine Sputnik V, developed by the Gamaleya Institute. "Commenting on the accusations against Russia is getting more and more circus-like," Peskov said in a conference call with reporters Friday. "Russia is not misinforming anyone, Russia proudly talks about its successes and Russia shares its successes regarding the first ever registered [coronavirus] vaccine in the world.

Brazilian media did not identify the deceased by name, saying only he was 28 years old and either a doctor or a medical student. It remains unknown whether the man was taking the AstraZeneca vaccine client or was part of a control group taking the placebo. The clinical data has to be kept confidential to

Brazilian pediatric doctor Monica Levi, one of the volunteers who received the COVID -19 vaccine , works at the Specialized Clinic in Infectious and Parasitic AstraZeneca shares turned negative Wednesday after a Brazilian health authority said a volunteer in its coronavirus vaccine study died .

Media reports said the volunteer was a 28-year-old doctor working on the front lines of the pandemic who died of complications from Covid-19.

Brazilian newspaper Globo and international news agency Bloomberg said he was in the control group and had received a placebo rather than the test vaccine, citing sources close to the trials.

"Following careful assessment of this case in Brazil, there have been no concerns about safety of the clinical trial, and the independent review in addition to the Brazilian regulator have recommended that the trial should continue," Oxford said in a statement.

AstraZeneca said medical confidentiality meant it could not give details on any individual volunteer, but that independent review had "not led to any concerns about continuation of the ongoing study."

Vaccine storage demands could leave 3B people in virus cold

  Vaccine storage demands could leave 3B people in virus cold GAMPELA, Burkina Faso (AP) — From factory to syringe, the world’s most promising coronavirus vaccine candidates need nonstop sterile refrigeration to work. But despite great strides in equipping developing countries to maintain the vaccine “cold chain,” nearly 3 billion of the world's 7.8 billion people live in places with insufficient temperature-controlled storage for an immunization campaign to bring COVID-19 under control. The result: PoorBut despite great strides in equipping developing countries to maintain the vaccine “cold chain,” nearly 3 billion of the world's 7.8 billion people live in places with insufficient temperature-controlled storage for an immunization campaign to bring COVID-19 under control.

A participant who died during an AstraZeneca Plc Covid -19 trial in Brazil hadn’t received the company’s Local newspapers earlier reported that a Brazilian volunteer had died from complications from the AstraZeneca is co -developing its shot with researchers at the University of Oxford .

Volunteers in Brazil have begun receiving a trial vaccine against COVID -19, in Latin America’s first phase 3 COVID -19 clinical trial. Vaccinations will take place in Sao Paulo, Rio de Janeiro and a site in the Northeast of Brazil . The Brazilian Health Regulatory Agency (ANVISA) approved the inclusion

Brazil's national health regulator, Anvisa, confirmed it had been notified of the case on October 19.

The D'Or Teaching and Research Institute (IDOR), which is helping organize the tests in Brazil, said the independent review had "raised no doubts about the safety of the study, and recommended it continue."

Oxford and AstraZeneca previously had to suspend testing of the vaccine in September when a volunteer in Britain developed an unexplained illness.

Trials resumed after British regulators and an independent review concluded the illness was not a side effect of the vaccine.

Half the volunteers in the final-stage clinical trial -- a double-blind, randomized, controlled study -- receive a placebo, IDOR said.

Around 8,000 volunteers have been vaccinated so far in Brazil, and more than 20,000 worldwide, it said.

Study participants must be doctors, nurses or other health sector workers who come into regular contact with the virus.

The deceased volunteer was a young doctor who had been treating Covid-19 patients since March in the emergency rooms and intensive care units at two hospitals in Rio de Janeiro, Globo said.

He graduated from medical school last year, and was in good health prior to contracting the disease, family and friends told the newspaper.

jhb/jm

Brothel loophole, ice rink outbreaks, White House Halloween: News from around our 50 states .
How the COVID-19 pandemic is affecting every stateStart the day smarter. Get all the news you need in your inbox each morning.

usr: 0
This is interesting!